If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,049.50    0.00 (0.00%)
Bid:
1,000.00
Ask:
1,203.00
Spread: 203.00 (20.30%)
Market Cap: £3.37b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Statement

8 Jan 2009 07:00

RNS Number : 2994L
Persimmon PLC
08 January 2009
Β 

ο»Ώ

TRADING UPDATE - 8 JANUARY 2009

Persimmon plc announces the following trading update ahead of its Preliminary ResultsΒ for the year endedΒ 31 December 2008, which will be announced on TuesdayΒ 3 March 2009.

Results for the full year will be in line withΒ marketΒ expectations. We have legally completedΒ 10,202Β units at an average selling price ofΒ c.Β Β£172,000. This represents a turnover of c. Β£1.76Β billion.

Our emphasis on cash control has resulted in a reduction of totalΒ borrowingsΒ at the year endΒ toΒ c. Β£600 million (June 2008: Β£906Β million). As anticipated at the time of our Interim Results on 21 August 2008 we have generated good net cash inflow from operations through the second half of 2008. Close control of work in progress includingΒ the focus on sales of stock properties andΒ overΒ 50% reductionΒ inΒ part exchangeΒ holdings has resulted in thisΒ strongΒ cash generation,Β despite theΒ previously reportedΒ deterioration in trading conditions encountered from early September 2008. The year end borrowings are lower than originally anticipated due to the early receipt of tax repayment following the provisions announced inΒ ourΒ Interim Management StatementΒ on 27 October 2008.

Until there is an improvement in theΒ restricted credit conditionsΒ currently experiencedΒ we will continue to focus on conservingΒ cash. As a consequenceΒ the Board does not intendΒ to pay a final dividend this year.

In addition, we have commenced discussions for theΒ plannedΒ refinancing of the Group's credit facilities. Having made good progress, our bank syndicate and private placement investors are actively engaged in establishing facilities appropriate for the future needs of the business together with covenants reflective of current credit market conditions.

Whilst we believe that the long term future for theΒ UKΒ housing market remains good, the short term outlookΒ isΒ challenging. However, we currentlyΒ haveΒ forwardΒ sales ofΒ c.Β Β£400 million.

Further details ofΒ the Group'sΒ performance for the yearΒ together with aΒ generalΒ market update will be providedΒ withΒ the announcement ofΒ our Results forΒ the year ended 31 DecemberΒ 2008,Β onΒ Tuesday 3Β March 2009.

For further information, please contact:

Persimmon plc

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

On 8 JanuaryΒ 2009:Β  +44 (0) 207Β 153 1533

Thereafter: +44 (0) 1904 642 199Β 

M: Communications

Edward Orlebar:Β  +44 (0) 207Β 153 1523Β / +44 (0) 7738 724 630

Charlotte McMullen:Β  +44 (0) 207 153 1549 / +44 (0) 7921 881 800

Marylene GuernierΒ  +44 (0) 207 153 1269 / +44 (0) 7776 303 788

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBRMRTMMIMBFL
Date   Source Headline
1st Jul 202610:12 amRNSAdmission to Trading
1st Jul 202610:09 amRNSTotal Voting Rights
1st Jun 202610:06 amRNSAdmission to Trading
1st Jun 202610:03 amRNSTotal Voting Rights
29th May 202611:57 amRNSDirector/PDMR Shareholding
11th May 20264:56 pmRNSHolding(s) in Company
1st May 202612:12 pmRNSAdmission to Trading
1st May 202612:06 pmRNSTotal Voting Rights
30th Apr 20262:19 pmRNSResult of AGM
30th Apr 20262:18 pmRNSHolding(s) in Company
30th Apr 20267:00 amRNSAGM Trading Statement
23rd Apr 20269:21 amRNSHolding(s) in Company
1st Apr 20261:45 pmRNSAdmission to Trading
1st Apr 20261:43 pmRNSTotal Voting Rights
30th Mar 20263:06 pmRNSDirector/PDMR Shareholding
24th Mar 20263:20 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:12 pmRNSAnnual Report 2025 and Notice of AGM 2026
10th Mar 20267:00 amRNSFull Year Results
2nd Mar 202611:26 amRNSTotal Voting Rights
18th Feb 20261:33 pmRNSNew Issue of Equity Securities
2nd Feb 202610:00 amRNSTotal Voting Rights
13th Jan 20267:00 amRNS2025 Trading Statement
2nd Jan 202612:52 pmRNSTotal Voting Rights
2nd Jan 202611:09 amRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
1st Dec 20252:58 pmRNSBlock listing Interim Review
1st Dec 202512:39 pmRNSTotal Voting Rights
27th Nov 202511:47 amRNSHolding(s) in Company
13th Nov 20257:00 amRNSQ3 Trading Statement
3rd Nov 202511:43 amRNSTotal Voting Rights
1st Oct 202511:45 amRNSTotal Voting Rights
30th Sep 202512:58 pmRNSDirector/PDMR Shareholding
26th Sep 20255:33 pmRNSHolding(s) in Company
17th Sep 20254:44 pmRNSHolding(s) in Company
9th Sep 202510:14 amRNSDirector/PDMR Shareholding
1st Sep 20252:31 pmRNSTotal Voting Rights
13th Aug 20257:00 amRNSHalf Year Results
1st Aug 202511:36 amRNSTotal Voting Rights
9th Jul 20257:23 amRNSUK CMA proposes closure of its investigation
4th Jul 20251:44 pmRNSHolding(s) in Company
1st Jul 202511:38 amRNSTotal Voting Rights
17th Jun 20253:47 pmRNSHolding(s) in Company
2nd Jun 20253:07 pmRNSBlock listing Interim Review
2nd Jun 202511:39 amRNSTotal Voting Rights
14th May 20257:00 amRNSSale of FibreNest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.